HDfarma SRL
0.4 FTEThe score of HDfarma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +82 % Total assets +27 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
HDfarma's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | 121,927 € | ||||
| Equity | 435,240 € | ||||
| Cash | 428,144 € | ||||
| EBITDA | 222,490 € | ||||
| Total assets | 779,162 € |
Filed annual accounts
- Year ended 31 Mar 2026filed on 29 Sep 2026
- Year ended 31 Mar 2025filed on 24 Oct 2025
- Year ended 31 Mar 2024filed on 03 Oct 2024
- Year ended 31 Mar 2023filed on 06 Sep 2023
- Year ended 31 Mar 2022filed on 22 Sep 2022
HDfarma's financial analysis
- Solvency55.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of HDfarma
HDfarma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0833.166.058
- VAT number
- BE0833166058
- Peppol
- Registered · 0208:0833166058 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Jan 2011
- Registered office
- 8210 Zedelgem
- Size
- Micro · 0.4 FTE
- Latest accounts
- 2026 · filed on 29 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
HDfarma (SRL) has been based in Zedelgem since 2011, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 121,927 € and equity of 435,240 €; its revenue is not published. With 0.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 55.9%, above the median of its sector (44.2%).
Companies similar to HDfarma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek De Vijzel Retail sale of pharmaceutical products Zoersel · balance sheet 509,493 €
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- Pharmacie Flawinne Retail sale of pharmaceutical products Jodoigne · balance sheet 794,460 €
- Biloba Heverlee Retail sale of pharmaceutical products Leuven · balance sheet 760,814 €
- Pharmeinsa Retail sale of pharmaceutical products Sankt Vith · balance sheet 757,173 €
- Apo-M Retail sale of pharmaceutical products Kortenberg · balance sheet 852,674 €
- LES Pharmacies Lambrechts Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 896,725 €
- Anglopharma Retail sale of pharmaceutical products De Panne · balance sheet 669,817 €
Frequently asked questions about HDfarma
What is the revenue of HDfarma?
HDfarma files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of HDfarma?
In Belgium, the VAT number is the company number prefixed with BE: BE0833166058 for HDfarma, if the company is VAT-registered. Its company number (CBE) is 0833.166.058.
Where is the registered office of HDfarma?
According to the CBE register, the registered office of HDfarma is in 8210 Zedelgem.
What is the equity of HDfarma?
At the close of the 2026 financial year, the equity of HDfarma amounts to 435,240 €, a solvency of 55.9% of total assets.
How many people work at HDfarma?
0.4 full-time equivalents on average according to the 2026 social balance sheet.
Who manages HDfarma?
The register lists 2 active mandates at HDfarma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of HDfarma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →